US FDA Withdraws Authorization of AstraZeneca’s Evusheld

Because it is not anticipated that AstraZeneca’s COVID-19 antibody cocktail Evusheld will neutralize the Omicron subvariant’s XBB.1.5 subvariant, the U.S. health regulator has revoked the treatment’s emergency-use authorization. Evusheld’s use had been restricted earlier this month for the same reason by the Food and Drug Administration (FDA), and the agency’s announcement on Thursday sent U.S. […]

Continue Reading

AstraZeneca and Sanofi gets European Approval for Drugs Preventing RSV for Infants

The European Commission (EC) approved Beyfortus, jointly developed by AstraZeneca and Sanofi, for the prevention of a common and highly contagious type of respiratory infection in infants. This long-acting therapy, which is also known as nirsevimab, was given marketing authorisation in the European Union (EU) for the prevention of disease from several infections caused by […]

Continue Reading

US FDA Warns, AstraZeneca’s Evusheld Ineffective against Omicron COVID-19 variants

The US Food and Drug Administration (FDA) of the United States, AstraZeneca’s Evusheld is proving ineffective against Omicron COVID-19 variants. Amid new reports, the antibody combination is ineffective against the latest subvariant of Omicron COVID-19 variants, including BA.4.6. The US FDA said that it can increase the risk of COVID-19 infection for the variants that […]

Continue Reading

AstraZeneca Enhertu Secures US FDA Approval for HER2-Low Breast Cancer

The US Food and Drug Administration (FDA) has approved Enhertu of AstraZeneca and Daiichi Sankyo for the treatment of adult patients with metastatic HER2-low breast cancer, who have received a prior chemotherapy in the metastatic setting during six months of completing adjuvant chemotherapy. Enhertu is a specifically designed HER2-directed antibody drug conjugate (ADC), that has […]

Continue Reading

AstraZeneca and Huma Partner to Accelerate Innovation for Digital-First Patient Care

Huma Therapeutics Limited, a digital health technology company has announced partnership with AstraZeneca for the purpose of scaling the innovation of digital health. This partnership has been following the prior use cases have been executed between AstraZeneca and Huma has been reflecting a shared ambition for the purpose of improving the clinical outcomes through the […]

Continue Reading